View item

US Department of Defense – Tuberous Sclerosis Complex Research Program (TSCRP) – Idea Development Award
Sponsor: US Department of Defense 		Closing Date: 11-Jul-2018
The Idea Development Award promotes ideas that have the potential to yield high-impact findings and new avenues of investigation. This award mechanism supports conceptually innovative research that could ultimately lead to critical discoveries in TSC research and/or improvements in patient care. Innovative research may introduce a new paradigm, challenge existing paradigms, look at existing problems from new perspectives, or exhibit other uniquely creative qualities that may include high-risk/potentially high-gain approaches to TSC research.

Eligibility
• Established Investigator: The PI must be an independent investigator at or above the level of Assistant Professor (or equivalent)
or
• New Investigators:
- By the application submission deadline, the PI must be either an independent investigator at or below the level of Assistant Professor (or equivalent) or an established investigator in an area other than TSC at or above the level of Assistant Professor seeking to transition to a career in TSC.
- Must not have received more than $300,000 in total direct costs for previous or concurrent TSC research as a PI of one or more Federally funded, non-mentored peer-reviewed grants. (National Institutes of Health K/R00 Awardees are eligible to apply.)
- Must not have received a New Investigator Award previously from any program within the CDMRP
- PIs must commit at least 10% of his/her effort toward the proposed TSC research project.
- Graduate students, postdoctoral fellows, and other “mentored” researchers are not eligible for this award.

Key Mechanism Elements
• Supports ideas that have the potential to yield high-impact findings and new avenues of investigation.
• Preliminary data expected.
• Clinical trials not allowed.
• New Investigator Option:
- Supports the continued development of promising independent investigators and/or the transition of established investigators from other research fields into a career in TSC research.
- Applications from New Investigators and Established Investigators will be peer and programmatically reviewed separately.

Funding
• Maximum funding of USD $450,000 for direct costs. Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
• Maximum period of performance is 3 years

Please see the U.S. Department of Defense Congressionally Directed Medical Research Program (CDMRP) website at http://cdmrp.army.mil/funding/tscrp and http://cdmrp.army.mil/tscrp/default for further information. Pre-applications are submitted via the CDMRP’s Electronic Biomedical Research Application Portal (EBRAP) and full applications are submitted via Grants.gov. For complete instructions for pre-applications and full applications, you must refer to both the Program Announcement and General Application Instructions documents.

Key Dates
Full applications due to UQR&I: 4 July 2018
Pre-applications (mandatory) close with US Department of Defense: 11 July 2018
Full applications close with US Department of Defense: 2 August 2018

Ahead of internal review, ensure all online components on EBRAP or Grants.gov are complete. To initiate review, email your completed Funding Application Coversheet to internationalgrants@research.uq.edu.au. Interested applicants are strongly encouraged to make contact with the UQR&I international team (internationalgrants@research.uq.edu.au) well in advance of the UQR&I internal deadline to discuss their application.
Website: http://cdmrp.army.mil/funding/tscrp

Return